SE420599B - Sett att framstella farmakologiskt aktiva derivat av 4-hydroxi-2-pyrrolidon - Google Patents

Sett att framstella farmakologiskt aktiva derivat av 4-hydroxi-2-pyrrolidon

Info

Publication number
SE420599B
SE420599B SE7608938A SE7608938A SE420599B SE 420599 B SE420599 B SE 420599B SE 7608938 A SE7608938 A SE 7608938A SE 7608938 A SE7608938 A SE 7608938A SE 420599 B SE420599 B SE 420599B
Authority
SE
Sweden
Prior art keywords
pyrrolidone
hydroxy
pharmacologically active
active derivatives
make
Prior art date
Application number
SE7608938A
Other languages
English (en)
Swedish (sv)
Other versions
SE7608938L (sv
Inventor
G Pifferi
M Pinza
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of SE7608938L publication Critical patent/SE7608938L/xx
Publication of SE420599B publication Critical patent/SE420599B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
SE7608938A 1975-08-13 1976-08-10 Sett att framstella farmakologiskt aktiva derivat av 4-hydroxi-2-pyrrolidon SE420599B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT26326/75A IT1045043B (it) 1975-08-13 1975-08-13 Derivati pirrolidinici

Publications (2)

Publication Number Publication Date
SE7608938L SE7608938L (sv) 1977-02-14
SE420599B true SE420599B (sv) 1981-10-19

Family

ID=11219233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608938A SE420599B (sv) 1975-08-13 1976-08-10 Sett att framstella farmakologiskt aktiva derivat av 4-hydroxi-2-pyrrolidon

Country Status (27)

Country Link
US (1) US4118396A (xx)
JP (1) JPS5822034B2 (xx)
AR (1) AR212176A1 (xx)
AT (1) AT353783B (xx)
AU (1) AU506651B2 (xx)
BE (1) BE845099A (xx)
CA (1) CA1077947A (xx)
CH (1) CH624935A5 (xx)
CS (1) CS214766B2 (xx)
DD (1) DD127966B3 (xx)
DE (1) DE2635853C2 (xx)
DK (1) DK156055C (xx)
ES (1) ES450643A1 (xx)
FI (1) FI62290C (xx)
FR (1) FR2320741A1 (xx)
GB (1) GB1550160A (xx)
HU (1) HU173742B (xx)
IN (1) IN144871B (xx)
IT (1) IT1045043B (xx)
MX (1) MX4717E (xx)
NL (1) NL179052C (xx)
NO (1) NO146909C (xx)
NZ (1) NZ181726A (xx)
PL (1) PL101471B1 (xx)
SE (1) SE420599B (xx)
SU (1) SU663302A3 (xx)
YU (1) YU40147B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1075280B (it) * 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
IT1075564B (it) 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
GB1580559A (en) * 1977-11-24 1980-12-03 Wyeth John & Brother Ltd Amide cerivatives
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
CA1124247A (en) * 1979-08-09 1982-05-25 Hoffmann-La Roche Limited Pyrrolidine derivatives
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
IT1206699B (it) * 1984-02-27 1989-04-27 Isf Spa Procedimento per preparare derivati di pirrolidone.
CH666483A5 (de) * 1985-01-16 1988-07-29 Lonza Ag Verfahren zur herstellung von thiotetronsaeure.
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0223328B1 (en) 1985-07-26 1992-01-29 Denki Kagaku Kogyo Kabushiki Kaisha Process for producing oxiracetam
IL80071A0 (en) * 1985-09-24 1986-12-31 Lonza Ag Pyrrolidine acetamide derivatives
CH668423A5 (de) * 1986-06-19 1988-12-30 Lonza Ag Verfahren zur herstellung von 4-alkoxy-3-pyrrolin-2-onen.
HU195773B (en) * 1985-09-24 1988-07-28 Lonza Ag Process for preparing alkyl esters of 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid
US4677114A (en) * 1985-11-22 1987-06-30 Warner-Lambert Company Pyrrolidone-2 derivatives and pharmaceutical compositions thereof
CH668422A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure.
CH668424A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on-l-yl-acetamid, dessen herstellung und verwendung.
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa
CH667655A5 (de) * 1986-09-24 1988-10-31 Lonza Ag Verfahren zur herstellung von 4-alkoxy-2(5h)-thiophenonen.
CH670644A5 (xx) * 1986-12-18 1989-06-30 Lonza Ag
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
DE3813416A1 (de) * 1988-04-21 1989-11-02 Hoechst Ag 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
JP2660201B2 (ja) * 1988-08-05 1997-10-08 塩野義製薬株式会社 新規ピロロ［１，４］ベンゾジアゼピン誘導体および老人性痴呆薬
EP0358128B1 (de) * 1988-09-06 1995-06-28 Lonza Ag Verfahren zur Herstellung von 5-Alkyltetramsäuren
HUT53607A (en) * 1989-01-17 1990-11-28 Hoffmann La Roche Process for production of derivatives of cyclohexan-acetamid
FI95034C (fi) * 1989-03-15 1995-12-11 Lonza Ag Menetelmä 1,3-substituoidun tetrahydro-1H-tieno/3,4-d/-imidatsol-2(3H)-on-4-ylideenipentaanihappoesterin valmistamiseksi
CH680293A5 (xx) * 1990-06-26 1992-07-31 Lonza Ag
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
CN1484527A (zh) 2000-12-28 2004-03-24 ��һ��������ҩ��ʽ���� 神经性疼痛治疗和预防药
WO2007065634A1 (en) * 2005-12-07 2007-06-14 Ucb Pharma, S.A. 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
EP3260118B1 (en) 2008-10-16 2021-03-24 The Johns Hopkins University Methods and compositions for improving cognitive function
EA037187B1 (ru) * 2010-02-09 2021-02-17 Дзе Джонс Хопкинс Юниверсити Способ и композиция для лечения когнитивного расстройства
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
US11160785B2 (en) 2013-03-15 2021-11-02 Agenebio Inc. Methods and compositions for improving cognitive function
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
AU2016268096B2 (en) 2015-05-22 2021-04-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
CN105820102A (zh) * 2016-05-10 2016-08-03 武汉工程大学 奥拉西坦的合成工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011886B (de) * 1952-04-29 1957-07-11 Waldemar Kutscher Dr Ing Dr Me Verfahren zur Herstellung von Aminoalkylpyrrolen
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
US3541111A (en) * 1968-05-08 1970-11-17 Du Pont Pyrrolinecarboxanilide compounds
US3577432A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines

Also Published As

Publication number Publication date
FI762314A (xx) 1977-02-14
NL179052C (nl) 1986-07-01
FI62290B (fi) 1982-08-31
CA1077947A (en) 1980-05-20
FI62290C (fi) 1982-12-10
NZ181726A (en) 1978-09-20
JPS5822034B2 (ja) 1983-05-06
ES450643A1 (es) 1977-08-01
CH624935A5 (xx) 1981-08-31
DD127966B3 (de) 1983-03-30
NO146909B (no) 1982-09-20
FR2320741A1 (fr) 1977-03-11
GB1550160A (en) 1979-08-08
US4118396A (en) 1978-10-03
SU663302A3 (ru) 1979-05-15
ATA589476A (de) 1979-05-15
NO762791L (xx) 1977-02-15
AU506651B2 (en) 1980-01-17
DD127966A5 (de) 1977-10-26
NL7608946A (nl) 1977-02-15
CS214766B2 (en) 1982-05-28
FR2320741B1 (xx) 1979-03-02
IN144871B (xx) 1978-07-22
AR212176A1 (es) 1978-05-31
IT1045043B (it) 1980-04-21
AU1679776A (en) 1978-02-16
SE7608938L (sv) 1977-02-14
MX4717E (es) 1982-08-13
HU173742B (hu) 1979-08-28
YU40147B (en) 1985-08-31
DE2635853C2 (de) 1984-05-30
DK365176A (da) 1977-02-14
BE845099A (fr) 1977-02-11
NL179052B (nl) 1986-02-03
PL101471B1 (pl) 1978-12-30
DE2635853A1 (de) 1977-02-24
DK156055C (da) 1989-12-04
DK156055B (da) 1989-06-19
JPS5223072A (en) 1977-02-21
AT353783B (de) 1979-12-10
NO146909C (no) 1982-12-29
YU196476A (en) 1982-06-30

Similar Documents

Publication Publication Date Title
SE420599B (sv) Sett att framstella farmakologiskt aktiva derivat av 4-hydroxi-2-pyrrolidon
SE433222B (sv) Sett att framstella modifierad polysackarid
SE419645B (sv) Sett att framstella 3-amino-indazolkarbonylsyra derivat
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE439485B (sv) Sett att framstella nya alkyloximderivat av 7-aminotiazolyl-acetamidocefalosporansyra
SE433492B (sv) Sett att framstella fenylettiksyraderivat
SE431088B (sv) Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat
SE445039B (sv) Sett att framstella cement av portlandtyp
SE7607240L (sv) Sett att framstella pyrrolettiksyraforeningar
SE431544B (sv) Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
SE437155B (sv) Sett att framstella nya derivat av perhydro-aza-heterocykler
SE7609886L (sv) Diacylerade derivat av y-glutamyldopamin
SE7608927L (sv) Sett att framstella pyridinderivat
SE415971B (sv) Sett att framstella substituerade bensamider med terapeutisk verkan
NO145950C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider
SE417090B (sv) Forfarande att framstella farmakologiskt aktiva heterocykliska prostaglandinanaloger
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE427272B (sv) Framstellning av nikotinamid
SE432926B (sv) Sett att framstella disubstituerade fenoletrar av 3-amino-2-hydroxipropan
SE412233B (sv) Sett att framstella nya fenotiazinderivat
SE7609666L (sv) Sett att framstella nya 5-aminometyltiazolderivat
SE417091B (sv) Forfarande att framstella farmakologiskt aktiva derivat av 2-karboxialkyl-4,4dimetyl-pyrrolidin-5-on
SE432588B (sv) Sett att framstella substituerade fenyl-alkyl-karboxylsyror

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7608938-2

Effective date: 19940310

Format of ref document f/p: F